Rise in Incidence of Cervical Cancer to Drive Global Vaginal Specula Market

According to our new market research study, titled "Vaginal Specula Market to 2028 - Global Analysis and Forecast - by Product, Type, Procedure, and End User," the market is expected to grow from US$ 955.7 million in 2022 to US$ 1,180.4 million by 2028; it is estimated to grow at a CAGR of 3.6% from 2022 to 2028. The report highlights trends prevailing in the market and drivers and restraints pertaining to the global vaginal specula market growth.

A vaginal speculum is a medical device typically used to examine vaginal orifices by doctors and medical practitioners. It is either a metal-based or non-metal medical device that gynecologists use to open the vaginal wall to examine the vagina and cervix and extract cervical cells for PAP or smear examination.

The rise in the incidence of cervical cancer and an increasing number of diagnostics services for women's health are expected to boost the growth of the global vaginal specula market during the forecast period. However, the market is likely to be impacted by complications associated with gynecological procedures during the forecast period. A speculum-based screening is required for Pap smear cervical cancer screening. Easy prevention and treatment are encouraging more women to undergo diagnosis and take treatment if the results of diagnosis are positive, thereby increasing the demand for vaginal specula.

North America holds the largest market share of the vaginal specula market, whereas Asia Pacific is expected to register the highest CAGR during the forecast period. The increasing prevalence of gynecology disorders, a vast incidence rate of cervical cancer, and increasing emphasis on women's health favor the growth of the vaginal specula market in the region. The vaginal specula market in the US is expected to grow from US$ 308.41 million in 2022 to US$ 391.18 million by 2028 at a CAGR of 4.0% during the forecast period. The highest incidence rate of cervical cancer is reported in Hispanic women. As per a study conducted by the CDC, white women had the highest incidence rate of uterine cancer (27.16 per 100,000), vulvar cancer (2.80 per 100,000), and ovarian cancer (11.50 per 100,000). Further, the highest incidence rate of vaginal cancer was observed among black women in the US. Thus, the high incidence of these types of cancer is contributing to the growth of the vaginal specula market in North America.

In the US, the National Program of Cancer Registries (NPCR), funded by the Centers for Disease Control and Prevention (CDC), is a population-based surveillance system of cancer registries. Through the NPCR, the CDC supports central cancer registries in 46 states, the US Pacific Island Jurisdictions, Puerto Rico, the District of Columbia, and the US Virgin Islands. Cancer is one of the significant health issues among women in the country. As per the study conducted by the CDC, 42,275 females died of breast cancer, 63,135 females died of lung cancer, 23,826 females died of colorectal cancer, and 22,495 females died of pancreatic cancer. According to the American Cancer Society, in 2022, ~19,880 women in the US were diagnosed with ovarian cancer, and ~12,810 women succumbed to death by this disease. In recent years, uterine cancer has been the most common gynecologic cancer in the US, and vaginal cancer has been the least common cancer reported among women. This is driving the market for vaginal specula in the US.

The COVID-19 pandemic hugely impacted Asia Pacific countries as it tested the resilience of economies and placed immense pressure on health workers. A socio-economic analysis of the impact of the pandemic by the United Nations Development Program (UNDP) helped governments overhaul policies and invest in public health, economic stimulus, and social safety. These measures helped countries recover faster from the adversities caused by the COVID-19 crisis. Governments ensured an uninterrupted availability of life-supporting medical equipment, including X-ray machines, infrared thermometers, infusion pumps, protective suits, gloves, hand sanitizers, and digital tools. The UNDP shifted its focus on long-term socio-economic goals that involve rebuilding a resilient and green future. Through these goals, the governments focus on helping countries manage complexities and uncertainties in four vital areas-governance, social protection, the green economy, and digital disruption. Furthermore, India, Bangladesh, Indonesia, and other countries encouraged digital innovations.

The COVID-19 pandemic has broadly affected several economies such as Japan, India, Australia, China, and South Korea. The supply chain disturbances and the tremendous demand for efficient treatments for COVID-19 have put the healthcare research industry in a crucial situation in Asia Pacific. Various control measures have been taken to control the spread of COVID-19.

The implementation of various preventive measures such as deliberately increasing the physical space to avoid spreading illness and mandating the use of masks in workplaces was aimed to reduce the spread of SARS-CoV-2. Furthermore, these restrictions resulted in the cancellation of several gynecologists' appointments due to the exorbitant rise in COVID-19 cases in Asia Pacific countries such as India and China. However, many other patients had appointments for gynecologic issues with low and medium-level priority, such as follow-ups and regular treatment, were postponed, which readily affected the vaginal specula market.

Cooper Companies, Inc.; Baxter International Inc; BD; B. Braun Melsungen AG; Teleflex Incorporated; Integra Lifesciences Holdings Corporation; Steris plc.; Robinson healthcare; Dynarex Corporation; and OBP Medical Corporation are the leading companies operating in the global vaginal specula market.

By geography, the vaginal specula market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South and Central America).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com